Terms: = Lymphoma AND ASXL1, ENSG00000171456, 171023, Q8IXJ9, MGC71111, MGC117280, KIAA0978 AND Prognosis
21 results:
1. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
[TBL] [Abstract] [Full Text] [Related]
2. Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.
Aldea M; Tagliamento M; Bayle A; Vasseur D; Vergé V; Marinello A; Danlos FX; Blanc-Durand F; Bernard E; Cerbone L; Mosele MF; Renneville A; Hadoux J; Loriot Y; Sakkal M; Vozy A; Sarkozy C; Smolenschi C; Nicotra C; Martin-Romano P; Boccon-Gibod C; Habza W; Lazarovici J; Ponce S; Hollebecque A; Marzac C; Lacroix L; Barlesi F; André F; Besse B; Rouleau E; Italiano A; Micol JB
JCO Precis Oncol; 2023 Mar; 7():e2200583. PubMed ID: 36862966
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias.
Testa S; Kumar J; Goodell AJ; Zehnder JL; Alexander KM; Sidana S; Arai S; Witteles RM; Liedtke M
Semin Oncol; 2022 Dec; 49(6):465-475. PubMed ID: 36503855
[TBL] [Abstract] [Full Text] [Related]
4. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
[TBL] [Abstract] [Full Text] [Related]
5. SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome.
Falantes JF; Márquez-Malaver FJ; Carrillo E; Culebras MG; Morales R; Prats C; Vargas MT; Caballero T; Rodríguez-Arbolí E; Espigado I; Pérez-Simón JA
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1059-e1066. PubMed ID: 36117041
[TBL] [Abstract] [Full Text] [Related]
6. The characteristics and clinical prognosis analysis of asxl1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing.
Xu J; Hao Z; Chen X; Hong M; Muyey DM; Chen X; Wang H
Leuk Lymphoma; 2022 Oct; 63(10):2321-2329. PubMed ID: 35652795
[TBL] [Abstract] [Full Text] [Related]
7. Predictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis.
Hu C; Wang X
Leuk Lymphoma; 2022 Oct; 63(10):2336-2351. PubMed ID: 35543621
[TBL] [Abstract] [Full Text] [Related]
8. High Frequency of asxl1 and IDH Mutations in Young Acute Myeloid Leukemia Egyptian Patients.
El Nahass YH; Nader HA; Sabet S; Nooh HA; Bassiony H; Kamel M; Samra MA; Mahmoud HK; El Metnawy WH; El Refaey FA
Asian Pac J Cancer Prev; 2022 Mar; 23(3):977-984. PubMed ID: 35345371
[TBL] [Abstract] [Full Text] [Related]
9. Excellent prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Polprasert C; Niparuck P; Rattanathammethee T; Chuncharunee S; Kobbuaklee S; Songserm K; Suksusut A; Trithiphen S; Lanamtieng T; Kongkiatkamon S; Chanswangphuwana C; Lawasut P; Bunworasate U; Rojnuckarin P
Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e293-e299. PubMed ID: 34840089
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence prognosis, Treatment Outcome, and Risk of Cardiovascular Events.
Sant'Antonio E; Camerini C; Rizzo V; Musolino C; Allegra A
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):573-579. PubMed ID: 34078586
[TBL] [Abstract] [Full Text] [Related]
11. Co-occurrence of
Jin H; Zhu Y; Hong M; Wu Y; Qiu H; Wang R; Jin H; Sun Q; Fu J; Li J; Qian S; Qiao C
Leuk Lymphoma; 2021 Oct; 62(10):2428-2437. PubMed ID: 34024223
[TBL] [Abstract] [Full Text] [Related]
12. HIV portends a poor prognosis in myelodysplastic syndromes.
Kaner JD; Thibaud S; Jasra S; Wang Y; Janakiram M; Sharma A; Sridharan A; Elias H; Polineni R; Assal A; Weiss L; Braunschweig I; Steidl U; Pradhan K; Shastri A; Chaitowitz M; Zingman B; Will B; Mantzaris I; Verma A
Leuk Lymphoma; 2019 Dec; 60(14):3529-3535. PubMed ID: 31282240
[TBL] [Abstract] [Full Text] [Related]
13. asxl1 is a molecular predictor in idiopathic cytopenia of undetermined significance.
Shin DY; Park JK; Kim SM; Im K; Kim JA; Kim SY; Hwang SM; Yoon SS; Lee DS
Leuk Lymphoma; 2019 Mar; 60(3):756-763. PubMed ID: 30301403
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Markers and prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
Lee YC; Hsieh CC; Lee YL; Li CY
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):558-568. PubMed ID: 29970342
[TBL] [Abstract] [Full Text] [Related]
15. asxl1 mutations in AML are associated with specific clinical and cytogenetic characteristics.
Kakosaiou K; Panitsas F; Daraki A; Pagoni M; Apostolou P; Ioannidou A; Vlachadami I; Marinakis T; Giatra C; Vasilatou D; Sambani C; Pappa V; Manola KN
Leuk Lymphoma; 2018 Oct; 59(10):2439-2446. PubMed ID: 29411666
[TBL] [Abstract] [Full Text] [Related]
16. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.
Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
[TBL] [Abstract] [Full Text] [Related]
17. prognosis of Primary Myelofibrosis in the Genomic Era.
Bose P; Verstovsek S
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S105-13. PubMed ID: 27521306
[TBL] [Abstract] [Full Text] [Related]
18. Transformation of the Clinical Management of CMML Patients Through In-Depth Molecular Characterization.
Sallman DA; Padron E
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S50-5. PubMed ID: 26297278
[TBL] [Abstract] [Full Text] [Related]
19. Functional and cancer genomics of ASXL family members.
Katoh M
Br J Cancer; 2013 Jul; 109(2):299-306. PubMed ID: 23736028
[TBL] [Abstract] [Full Text] [Related]
20. Update on cytogenetic and molecular changes in myelodysplastic syndromes.
Schlegelberger B; Göhring G; Thol F; Heuser M
Leuk Lymphoma; 2012 Apr; 53(4):525-36. PubMed ID: 21877899
[TBL] [Abstract] [Full Text] [Related]
[Next]
